FDA Approved: FLUVASTATIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA supplemental application for Fluvastatin submitted by Teva Pharmaceuticals USA, Inc. related to labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hyperlipidemia

Drugs mentioned

• Fluvastatin (fluvastatin)
• Lescol (fluvastatin)

Snippet

SUPPL AP for FLUVASTATIN (FLUVASTATIN)